Post by Eurofins India

When it comes to pharmaceutical safety, even trace-level genotoxic impurities (GTIs) require precise detection, robust risk assessment, and complete regulatory confidence.   At Eurofins, BioPharma Product Testing India, we combine scientific expertise with advanced analytical technologies to support pharmaceutical and biopharmaceutical companies in meeting global regulatory expectations for impurity analysis and product quality.   Our key capabilities include: ✔ Genotoxic Impurity Evaluation (ICH M7 compliant) ✔ Nitrosamine & Trace-Level Impurity Analysis ✔ Method Development, Validation & Transfer ✔ Residual Solvent & Elemental Impurity Testing ✔ Regulatory-ready analytical support using GC-MS/MS, LC-MS/MS & ICP-MS   With cGMP-compliant laboratories and globally aligned testing approaches, we help our partners strengthen impurity control strategies, accelerate development timelines, and deliver safer medicines to patients worldwide.   📩 Contact us - [email protected]   Learn more: https://lnkd.in/dYhRdzhz   #BPTIndia #Eurofins #GenotoxicImpurities #NitrosamineTesting #PharmaceuticalTesting #DrugSafety #RegulatoryCompliance #AnalyticalTesting #LCMSMS #GCMSMS #PharmaceuticalDevelopment